Zivira Labs

Zivira Labs is a specialty pharmaceutical company headquartered in Chennai, India, focusing on the development and commercialization of high-quality oncology and critical care medicines. The company specializes in "Value Added Medicines" (VAMs) and complex generics, aiming to improve patient outcomes through innovative drug delivery systems and enhanced formulations. Zivira's portfolio primarily targets various solid tumors and hematological disorders, leveraging a robust R&D infrastructure to navigate complex regulatory pathways such as the 505(b)(2) route. They operate with a global outlook, seeking to provide affordable yet advanced therapeutic options in both emerging and regulated markets. The firm emphasizes strategic partnerships for manufacturing to ensure a reliable supply of life-saving treatments.